Atlanta, GA – Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, announced today the selection of four finalists in its first annual BIO/Plan Competition. The final four competitors are: CureFAKtor, Inc. (University of Florida); Triptor Pharmaceuticals (Emory University); SpherIngenics, Inc. (Georgia Institute of Technology); and Oncoscope, Inc. (Duke University). (more…)

Atlanta, GA – Southeast BIO (SEBIO) today announced the keynote speakers and featured panelists for the Ninth Annual Southeastern BIO Investor Forum. The Forum, scheduled for November 7-8, 2007 at the Pinehurst Resort in Pinehurst, NC, will feature remarks from more than 14 industry leaders. (more…)

Atlanta, GA– Southeast BIO (SEBIO) announced today it has selected 24 companies to participate in its Southeastern BIO Investor Forum, an event that brings together the Southeast’s most promising life sciences venture opportunities with the regional and national venture capital community. (more…)

Atlanta, GA– Southeast BIO (SEBIO) has elected four new members to its Board of Directors to lead the organization. The new members of SEBIO’s Board of Directors include Thomas Brooks, HealthCare Capital Partners; David L. Brumfield, Smith & Nephew; Gerard van Hamel Platerink, Accuitive Medical Ventures; Stephen Snowdy, MB Venture Partners. (more…)

By Rebecca J. Kaufman

The promise of stem cell technology has generated more than a few headlines. So too have the politics of stem cells, namely human embryonic stem cells (hESC). As recently as last week, President Bush vetoed a bill that would have authorized expanded federal support for hESC research, citing moral issues. In the absence of new legislation, federal funding is limited to research on hESC lines derived before August 9, 2001; which many researchers have argued are inadequate. (more…)

Atlanta, GA - Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, announced today that it has selected ten finalists in its first annual BIO/Plan Competition. (more…)

Southeast BIO (SEBIO), a public/private partnership formed in 1999 to promote the growth of the life sciences economy in the Southeast, has named Stephanie Adams, Ph.D., as its new Executive Director. Dr. Adams replaces Anne Wein, SE Bio’s first Executive Director. Wein announced her resignation in early January in anticipation of the birth of her first child in March. (more…)